ARTICLE | Company News
EC approves Piramal's NeuraCeq imaging agent
February 25, 2014 1:03 AM UTC
The European Commission approved NeuraCeq [18F]- florbetaben from Piramal Enterprises Ltd. (BSE:PEL; NSE:PEL) for PET imaging of beta amyloid neuritic plaque density in adults with cognitive impairmen...